- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cell Therapy market report explains the definition, types, applications, major countries, and major players of the Cell Therapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Novartis AG
NuVasive Inc
GlaxoSmithKline plc
Grupo Praxis
Dendreon
Genzyme Corporation
Mesoblast
Cognate
MEDIPOST
Cynata
Pluristem
PHARMICELL
EUFETS GmbH
JCR Pharmaceuticals CO LTD
ANTEROGENCO LTD
Advanced Tissue
BioNTech IMFS
Osiris
CELLECTIS
Vericel
By Type:
Autologous
Allogeneic
By End-User:
Hospitals and clinics
ASCs
Regenerative medicine centers
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Cell Therapy Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Cell Therapy Outlook to 2028- Original Forecasts
-
2.2 Cell Therapy Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Cell Therapy Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Cell Therapy Market- Recent Developments
-
6.1 Cell Therapy Market News and Developments
-
6.2 Cell Therapy Market Deals Landscape
7 Cell Therapy Raw Materials and Cost Structure Analysis
-
7.1 Cell Therapy Key Raw Materials
-
7.2 Cell Therapy Price Trend of Key Raw Materials
-
7.3 Cell Therapy Key Suppliers of Raw Materials
-
7.4 Cell Therapy Market Concentration Rate of Raw Materials
-
7.5 Cell Therapy Cost Structure Analysis
-
7.5.1 Cell Therapy Raw Materials Analysis
-
7.5.2 Cell Therapy Labor Cost Analysis
-
7.5.3 Cell Therapy Manufacturing Expenses Analysis
8 Global Cell Therapy Import and Export Analysis (Top 10 Countries)
-
8.1 Global Cell Therapy Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Cell Therapy Export by Region (Top 10 Countries) (2017-2028)
9 Global Cell Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Cell Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Autologous Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Allogeneic Consumption and Growth Rate (2017-2022)
-
9.2 Global Cell Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals and clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global ASCs Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Regenerative medicine centers Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Cell Therapy Market Analysis and Outlook till 2022
-
10.1 Global Cell Therapy Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Cell Therapy Consumption (2017-2022)
-
10.2.2 Canada Cell Therapy Consumption (2017-2022)
-
10.2.3 Mexico Cell Therapy Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Cell Therapy Consumption (2017-2022)
-
10.3.2 UK Cell Therapy Consumption (2017-2022)
-
10.3.3 Spain Cell Therapy Consumption (2017-2022)
-
10.3.4 Belgium Cell Therapy Consumption (2017-2022)
-
10.3.5 France Cell Therapy Consumption (2017-2022)
-
10.3.6 Italy Cell Therapy Consumption (2017-2022)
-
10.3.7 Denmark Cell Therapy Consumption (2017-2022)
-
10.3.8 Finland Cell Therapy Consumption (2017-2022)
-
10.3.9 Norway Cell Therapy Consumption (2017-2022)
-
10.3.10 Sweden Cell Therapy Consumption (2017-2022)
-
10.3.11 Poland Cell Therapy Consumption (2017-2022)
-
10.3.12 Russia Cell Therapy Consumption (2017-2022)
-
10.3.13 Turkey Cell Therapy Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Cell Therapy Consumption (2017-2022)
-
10.4.2 Japan Cell Therapy Consumption (2017-2022)
-
10.4.3 India Cell Therapy Consumption (2017-2022)
-
10.4.4 South Korea Cell Therapy Consumption (2017-2022)
-
10.4.5 Pakistan Cell Therapy Consumption (2017-2022)
-
10.4.6 Bangladesh Cell Therapy Consumption (2017-2022)
-
10.4.7 Indonesia Cell Therapy Consumption (2017-2022)
-
10.4.8 Thailand Cell Therapy Consumption (2017-2022)
-
10.4.9 Singapore Cell Therapy Consumption (2017-2022)
-
10.4.10 Malaysia Cell Therapy Consumption (2017-2022)
-
10.4.11 Philippines Cell Therapy Consumption (2017-2022)
-
10.4.12 Vietnam Cell Therapy Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Cell Therapy Consumption (2017-2022)
-
10.5.2 Colombia Cell Therapy Consumption (2017-2022)
-
10.5.3 Chile Cell Therapy Consumption (2017-2022)
-
10.5.4 Argentina Cell Therapy Consumption (2017-2022)
-
10.5.5 Venezuela Cell Therapy Consumption (2017-2022)
-
10.5.6 Peru Cell Therapy Consumption (2017-2022)
-
10.5.7 Puerto Rico Cell Therapy Consumption (2017-2022)
-
10.5.8 Ecuador Cell Therapy Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Cell Therapy Consumption (2017-2022)
-
10.6.2 Kuwait Cell Therapy Consumption (2017-2022)
-
10.6.3 Oman Cell Therapy Consumption (2017-2022)
-
10.6.4 Qatar Cell Therapy Consumption (2017-2022)
-
10.6.5 Saudi Arabia Cell Therapy Consumption (2017-2022)
-
10.6.6 United Arab Emirates Cell Therapy Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Cell Therapy Consumption (2017-2022)
-
10.7.2 South Africa Cell Therapy Consumption (2017-2022)
-
10.7.3 Egypt Cell Therapy Consumption (2017-2022)
-
10.7.4 Algeria Cell Therapy Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Cell Therapy Consumption (2017-2022)
-
10.8.2 New Zealand Cell Therapy Consumption (2017-2022)
11 Global Cell Therapy Competitive Analysis
-
11.1 Novartis AG
-
11.1.1 Novartis AG Company Details
-
11.1.2 Novartis AG Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Novartis AG Cell Therapy Main Business and Markets Served
-
11.1.4 Novartis AG Cell Therapy Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 NuVasive Inc
-
11.2.1 NuVasive Inc Company Details
-
11.2.2 NuVasive Inc Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 NuVasive Inc Cell Therapy Main Business and Markets Served
-
11.2.4 NuVasive Inc Cell Therapy Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 GlaxoSmithKline plc
-
11.3.1 GlaxoSmithKline plc Company Details
-
11.3.2 GlaxoSmithKline plc Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 GlaxoSmithKline plc Cell Therapy Main Business and Markets Served
-
11.3.4 GlaxoSmithKline plc Cell Therapy Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Grupo Praxis
-
11.4.1 Grupo Praxis Company Details
-
11.4.2 Grupo Praxis Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Grupo Praxis Cell Therapy Main Business and Markets Served
-
11.4.4 Grupo Praxis Cell Therapy Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Dendreon
-
11.5.1 Dendreon Company Details
-
11.5.2 Dendreon Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Dendreon Cell Therapy Main Business and Markets Served
-
11.5.4 Dendreon Cell Therapy Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Genzyme Corporation
-
11.6.1 Genzyme Corporation Company Details
-
11.6.2 Genzyme Corporation Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Genzyme Corporation Cell Therapy Main Business and Markets Served
-
11.6.4 Genzyme Corporation Cell Therapy Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Mesoblast
-
11.7.1 Mesoblast Company Details
-
11.7.2 Mesoblast Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Mesoblast Cell Therapy Main Business and Markets Served
-
11.7.4 Mesoblast Cell Therapy Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Cognate
-
11.8.1 Cognate Company Details
-
11.8.2 Cognate Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Cognate Cell Therapy Main Business and Markets Served
-
11.8.4 Cognate Cell Therapy Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 MEDIPOST
-
11.9.1 MEDIPOST Company Details
-
11.9.2 MEDIPOST Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 MEDIPOST Cell Therapy Main Business and Markets Served
-
11.9.4 MEDIPOST Cell Therapy Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Cynata
-
11.10.1 Cynata Company Details
-
11.10.2 Cynata Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Cynata Cell Therapy Main Business and Markets Served
-
11.10.4 Cynata Cell Therapy Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Pluristem
-
11.11.1 Pluristem Company Details
-
11.11.2 Pluristem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Pluristem Cell Therapy Main Business and Markets Served
-
11.11.4 Pluristem Cell Therapy Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 PHARMICELL
-
11.12.1 PHARMICELL Company Details
-
11.12.2 PHARMICELL Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 PHARMICELL Cell Therapy Main Business and Markets Served
-
11.12.4 PHARMICELL Cell Therapy Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 EUFETS GmbH
-
11.13.1 EUFETS GmbH Company Details
-
11.13.2 EUFETS GmbH Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 EUFETS GmbH Cell Therapy Main Business and Markets Served
-
11.13.4 EUFETS GmbH Cell Therapy Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 JCR Pharmaceuticals CO LTD
-
11.14.1 JCR Pharmaceuticals CO LTD Company Details
-
11.14.2 JCR Pharmaceuticals CO LTD Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 JCR Pharmaceuticals CO LTD Cell Therapy Main Business and Markets Served
-
11.14.4 JCR Pharmaceuticals CO LTD Cell Therapy Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 ANTEROGENCO LTD
-
11.15.1 ANTEROGENCO LTD Company Details
-
11.15.2 ANTEROGENCO LTD Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 ANTEROGENCO LTD Cell Therapy Main Business and Markets Served
-
11.15.4 ANTEROGENCO LTD Cell Therapy Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Advanced Tissue
-
11.16.1 Advanced Tissue Company Details
-
11.16.2 Advanced Tissue Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Advanced Tissue Cell Therapy Main Business and Markets Served
-
11.16.4 Advanced Tissue Cell Therapy Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 BioNTech IMFS
-
11.17.1 BioNTech IMFS Company Details
-
11.17.2 BioNTech IMFS Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 BioNTech IMFS Cell Therapy Main Business and Markets Served
-
11.17.4 BioNTech IMFS Cell Therapy Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Osiris
-
11.18.1 Osiris Company Details
-
11.18.2 Osiris Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Osiris Cell Therapy Main Business and Markets Served
-
11.18.4 Osiris Cell Therapy Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 CELLECTIS
-
11.19.1 CELLECTIS Company Details
-
11.19.2 CELLECTIS Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 CELLECTIS Cell Therapy Main Business and Markets Served
-
11.19.4 CELLECTIS Cell Therapy Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Vericel
-
11.20.1 Vericel Company Details
-
11.20.2 Vericel Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Vericel Cell Therapy Main Business and Markets Served
-
11.20.4 Vericel Cell Therapy Product Portfolio
-
11.20.5 Recent Research and Development Strategies
12 Global Cell Therapy Market Outlook by Types and Applications to 2028
-
12.1 Global Cell Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Autologous Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Allogeneic Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Cell Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals and clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global ASCs Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Regenerative medicine centers Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Cell Therapy Market Analysis and Outlook to 2028
-
13.1 Global Cell Therapy Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Cell Therapy Consumption Forecast (2022-2028)
-
13.2.2 Canada Cell Therapy Consumption Forecast (2022-2028)
-
13.2.3 Mexico Cell Therapy Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Cell Therapy Consumption Forecast (2022-2028)
-
13.3.2 UK Cell Therapy Consumption Forecast (2022-2028)
-
13.3.3 Spain Cell Therapy Consumption Forecast (2022-2028)
-
13.3.4 Belgium Cell Therapy Consumption Forecast (2022-2028)
-
13.3.5 France Cell Therapy Consumption Forecast (2022-2028)
-
13.3.6 Italy Cell Therapy Consumption Forecast (2022-2028)
-
13.3.7 Denmark Cell Therapy Consumption Forecast (2022-2028)
-
13.3.8 Finland Cell Therapy Consumption Forecast (2022-2028)
-
13.3.9 Norway Cell Therapy Consumption Forecast (2022-2028)
-
13.3.10 Sweden Cell Therapy Consumption Forecast (2022-2028)
-
13.3.11 Poland Cell Therapy Consumption Forecast (2022-2028)
-
13.3.12 Russia Cell Therapy Consumption Forecast (2022-2028)
-
13.3.13 Turkey Cell Therapy Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Cell Therapy Consumption Forecast (2022-2028)
-
13.4.2 Japan Cell Therapy Consumption Forecast (2022-2028)
-
13.4.3 India Cell Therapy Consumption Forecast (2022-2028)
-
13.4.4 South Korea Cell Therapy Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Cell Therapy Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Cell Therapy Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Cell Therapy Consumption Forecast (2022-2028)
-
13.4.8 Thailand Cell Therapy Consumption Forecast (2022-2028)
-
13.4.9 Singapore Cell Therapy Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Cell Therapy Consumption Forecast (2022-2028)
-
13.4.11 Philippines Cell Therapy Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Cell Therapy Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Cell Therapy Consumption Forecast (2022-2028)
-
13.5.2 Colombia Cell Therapy Consumption Forecast (2022-2028)
-
13.5.3 Chile Cell Therapy Consumption Forecast (2022-2028)
-
13.5.4 Argentina Cell Therapy Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Cell Therapy Consumption Forecast (2022-2028)
-
13.5.6 Peru Cell Therapy Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Cell Therapy Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Cell Therapy Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Cell Therapy Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Cell Therapy Consumption Forecast (2022-2028)
-
13.6.3 Oman Cell Therapy Consumption Forecast (2022-2028)
-
13.6.4 Qatar Cell Therapy Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Cell Therapy Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Cell Therapy Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Cell Therapy Consumption Forecast (2022-2028)
-
13.7.2 South Africa Cell Therapy Consumption Forecast (2022-2028)
-
13.7.3 Egypt Cell Therapy Consumption Forecast (2022-2028)
-
13.7.4 Algeria Cell Therapy Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Cell Therapy Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Cell Therapy Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Cell Therapy
-
Figure of Cell Therapy Picture
-
Table Global Cell Therapy Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Cell Therapy Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Autologous Consumption and Growth Rate (2017-2022)
-
Figure Global Allogeneic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals and clinics Consumption and Growth Rate (2017-2022)
-
Figure Global ASCs Consumption and Growth Rate (2017-2022)
-
Figure Global Regenerative medicine centers Consumption and Growth Rate (2017-2022)
-
Figure Global Cell Therapy Consumption by Country (2017-2022)
-
Table North America Cell Therapy Consumption by Country (2017-2022)
-
Figure United States Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Canada Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Mexico Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Cell Therapy Consumption by Country (2017-2022)
-
Figure Germany Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure UK Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Spain Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Belgium Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure France Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Italy Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Denmark Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Finland Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Norway Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Sweden Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Poland Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Russia Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Turkey Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table APAC Cell Therapy Consumption by Country (2017-2022)
-
Figure China Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Thailand Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Singapore Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Philippines Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table South America Cell Therapy Consumption by Country (2017-2022)
-
Figure Brazil Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Colombia Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Chile Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Argentina Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Peru Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table GCC Cell Therapy Consumption by Country (2017-2022)
-
Figure Bahrain Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Oman Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Qatar Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Africa Cell Therapy Consumption by Country (2017-2022)
-
Figure Nigeria Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Africa Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Egypt Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Algeria Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Oceania Cell Therapy Consumption by Country (2017-2022)
-
Figure Australia Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Novartis AG Company Details
-
Table Novartis AG Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Cell Therapy Main Business and Markets Served
-
Table Novartis AG Cell Therapy Product Portfolio
-
Table NuVasive Inc Company Details
-
Table NuVasive Inc Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table NuVasive Inc Cell Therapy Main Business and Markets Served
-
Table NuVasive Inc Cell Therapy Product Portfolio
-
Table GlaxoSmithKline plc Company Details
-
Table GlaxoSmithKline plc Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Cell Therapy Main Business and Markets Served
-
Table GlaxoSmithKline plc Cell Therapy Product Portfolio
-
Table Grupo Praxis Company Details
-
Table Grupo Praxis Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grupo Praxis Cell Therapy Main Business and Markets Served
-
Table Grupo Praxis Cell Therapy Product Portfolio
-
Table Dendreon Company Details
-
Table Dendreon Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dendreon Cell Therapy Main Business and Markets Served
-
Table Dendreon Cell Therapy Product Portfolio
-
Table Genzyme Corporation Company Details
-
Table Genzyme Corporation Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Corporation Cell Therapy Main Business and Markets Served
-
Table Genzyme Corporation Cell Therapy Product Portfolio
-
Table Mesoblast Company Details
-
Table Mesoblast Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mesoblast Cell Therapy Main Business and Markets Served
-
Table Mesoblast Cell Therapy Product Portfolio
-
Table Cognate Company Details
-
Table Cognate Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cognate Cell Therapy Main Business and Markets Served
-
Table Cognate Cell Therapy Product Portfolio
-
Table MEDIPOST Company Details
-
Table MEDIPOST Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table MEDIPOST Cell Therapy Main Business and Markets Served
-
Table MEDIPOST Cell Therapy Product Portfolio
-
Table Cynata Company Details
-
Table Cynata Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cynata Cell Therapy Main Business and Markets Served
-
Table Cynata Cell Therapy Product Portfolio
-
Table Pluristem Company Details
-
Table Pluristem Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pluristem Cell Therapy Main Business and Markets Served
-
Table Pluristem Cell Therapy Product Portfolio
-
Table PHARMICELL Company Details
-
Table PHARMICELL Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table PHARMICELL Cell Therapy Main Business and Markets Served
-
Table PHARMICELL Cell Therapy Product Portfolio
-
Table EUFETS GmbH Company Details
-
Table EUFETS GmbH Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table EUFETS GmbH Cell Therapy Main Business and Markets Served
-
Table EUFETS GmbH Cell Therapy Product Portfolio
-
Table JCR Pharmaceuticals CO LTD Company Details
-
Table JCR Pharmaceuticals CO LTD Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table JCR Pharmaceuticals CO LTD Cell Therapy Main Business and Markets Served
-
Table JCR Pharmaceuticals CO LTD Cell Therapy Product Portfolio
-
Table ANTEROGENCO LTD Company Details
-
Table ANTEROGENCO LTD Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table ANTEROGENCO LTD Cell Therapy Main Business and Markets Served
-
Table ANTEROGENCO LTD Cell Therapy Product Portfolio
-
Table Advanced Tissue Company Details
-
Table Advanced Tissue Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advanced Tissue Cell Therapy Main Business and Markets Served
-
Table Advanced Tissue Cell Therapy Product Portfolio
-
Table BioNTech IMFS Company Details
-
Table BioNTech IMFS Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioNTech IMFS Cell Therapy Main Business and Markets Served
-
Table BioNTech IMFS Cell Therapy Product Portfolio
-
Table Osiris Company Details
-
Table Osiris Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Osiris Cell Therapy Main Business and Markets Served
-
Table Osiris Cell Therapy Product Portfolio
-
Table CELLECTIS Company Details
-
Table CELLECTIS Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table CELLECTIS Cell Therapy Main Business and Markets Served
-
Table CELLECTIS Cell Therapy Product Portfolio
-
Table Vericel Company Details
-
Table Vericel Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vericel Cell Therapy Main Business and Markets Served
-
Table Vericel Cell Therapy Product Portfolio
-
Figure Global Autologous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Allogeneic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals and clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ASCs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Regenerative medicine centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cell Therapy Consumption Forecast by Country (2022-2028)
-
Table North America Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Germany Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure China Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Brazil Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Australia Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-